Skip to content

Pharmanovia Acquires Exclusive Rights to Treatment for Parkinson’s Disease

By API User

– The Agreement Covers Australia and New Zealand – Pharmanovia Will Take Over Rights From CSL Seqirus and Will Be Responsible for All Commercial and Regulatory Activities – Deal Strengthens Foothold in Australia and New Zealand and Further Expands Our CNS Portfolio Offering BASILDON, U.K.–BUSINESS WIRE– Pharmanovia, a global pharmaceutical company that commercialises novel medicines … Continued

Haleon and the University of Sydney drive new osteoarthritis research

By API User

  Haleon is teaming up with the University of Sydney to launch a five-year fellowship to research the efficacy of dietary supplements for osteoarthritis   The collaboration will develop innovative, evidence-based strategies to help improve osteoarthritis management in Australia, and globally  Osteoarthritis is a painful and debilitating condition that affects over 2 million Australians, representing a … Continued

Hoarding disorder: ‘sensory CBT’ treatment strategy shows promise

By API User

A novel treatment strategy for hoarding disorder has demonstrated its potential in a pre-clinical study. Rehearsing alternative outcomes of discarding through imagery rescripting shows promise as a treatment strategy for people who hoard, a study by UNSW psychology researchers has shown. Hoarding disorder is a highly debilitating condition that worsens with age. People who hoard form intense … Continued

Health of the Nation 2024 reveals Australia’s ‘most satisfied’ GPs

By API User

Australia’s ‘most satisfied’ GPs are working in health services designed and governed by Aboriginal and Torres Strait Islander communities, according to the Royal Australian College of GPs Health of the Nation 2024 report.  The RACGP’s Health of the Nation report is the only annual report providing insights into general practice care based on a nationwide … Continued

New report: Investment in adult vaccination can deliver a $1.1bn net annual return

By API User

Increasing investment in adult immunisation has the potential to deliver $1.1 billion in benefits every year, according to a new report commissioned by GSK, examining the opportunity to increase access to vaccination and disease prevention.1   Prevention: A Productivity Superpower was launched by GSK Australia at Parliament House, Canberra today and demonstrates that every dollar … Continued

Curia Unveils Brand Refresh at CPHI WW in Milan

By API User

The refined brand highlights Curia’s key capabilities and personalized approach across small molecules, generic APIs and biologics ALBANY, N.Y., Oct. 07, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today unveiled its refreshed brand. The update introduces refined corporate messaging and a new brand hierarchy, highlighting the breadth of Curia’s … Continued